PBM

Propel Bio Management Portfolio holdings

AUM $99.9M
1-Year Est. Return 12.07%
This Quarter Est. Return
1 Year Est. Return
+12.07%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$86.1M
AUM Growth
-$14.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
23
New
Increased
Reduced
Closed

Top Buys

1
+$2.04M
2
+$1.16M
3
+$909K
4
APLT icon
Applied Therapeutics
APLT
+$816K
5
CMPX icon
Compass Therapeutics
CMPX
+$434K

Top Sells

1
+$4.82M
2
+$4.65M
3
+$4.31M
4
KYMR icon
Kymera Therapeutics
KYMR
+$2.27M
5
KURA icon
Kura Oncology
KURA
+$1.13M

Sector Composition

1 Healthcare 67.17%
2 Energy 31.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$27.2M 31.57%
1,272,360
2
$9.95M 11.56%
30,032
-13,000
3
$9.27M 10.76%
228,884
-114,845
4
$7.12M 8.27%
1,134,927
+145,000
5
$6.55M 7.61%
2,453,092
6
$5.52M 6.41%
11,285,420
+1,670,000
7
$5.27M 6.12%
178,500
8
$2.97M 3.45%
624,022
9
$2.88M 3.35%
2,087,139
10
$2.26M 2.63%
177,600
+160,600
11
$2.25M 2.62%
183,259
12
$1.35M 1.57%
179,874
13
$1.16M 1.35%
+1,451,557
14
$434K 0.5%
+228,317
15
$425K 0.49%
149,279
16
$423K 0.49%
146,381
17
– –
-950,947
18
– –
-25,209
19
– –
-20,000
20
– –
-130,000
21
– –
-56,359